Frog Slime Peptide as a Universal Vaccine?

News

Emory scientists have discovered a peptide, urumin, in frog slime that disrupts the integrity of the flu virus.

Read more

Seven days in science - 21 April 2017

Quiz

Test your knowledge of what's been happening in the scientific world over the past seven days.

Read more

Nanoparticles Reprogram Immune Cells to Fight Cancer in the Body

News

Fred Hutch researchers have developed nanoparticles that can deliver DNA to T-cells, reprogramming them to fight cancer, in the body.

Read more

Seven days in science - 10 March 2017

Quiz

Test your knowledge of what's been happening in the scientific world over the past seven days.

Read more
How Cancer Evades the Immune System
How Cancer Evades the Immune System
News

A team of scientists from Singapore has discovered new ways in which cancers can escape the body’s immune system.

Read more

Malaria Parasite Protein Shows Promise as Cancer Therapeutic
Malaria Parasite Protein Shows Promise as Cancer Therapeutic
News

A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

Read more

The Next Generation of Pancreatic Cancer Therapeutics
The Next Generation of Pancreatic Cancer Therapeutics
News

Currently, there are not many effective therapies available other than surgery, and that is not an option for many patients.

Read more

FDA Approves Pembrolizumab for Hodgkin Lymphoma
FDA Approves Pembrolizumab for Hodgkin Lymphoma
News

On March 14, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda®) for the treatment of some patients with classical Hodgkin lymphoma (cHL).

Read more

Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research
Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research
News

Prof. Stoll receives the award in support of his research, applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.

Read more

Synpromics Raise £5.2m in its Latest Fundraising Round
Synpromics Raise £5.2m in its Latest Fundraising Round
News

Synpromics, a leading synthetic promoter and gene control company has raised £5.2m in its latest funding round.

Read more